Search for: "Pfizer Pharmaceutic, Inc." Results 541 - 560 of 667
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jan 2009, 3:15 am
According to an article by The Legal Intelligencer, Pfizer Inc. has made no secret of its intentions to slash thousands of jobs once a planned merger with pharmaceutical competitor Wyeth goes through.How Wyeth's 300-person worldwide legal department will be affected is still a question mark. [read post]
27 Jan 2009, 2:53 pm
Margaret Cronin Fisk of Bloomberg News has reported that Pharmaceutical giant Pfizer Inc. has agreed to pay $2.3 billion to resolve inquiries into allegations that the drug maker improperly marketed the painkiller Bextra and other drugs. [read post]
26 Jan 2009, 12:47 am
Pfizer's lead advisers included Bank of America Merrill Lynch, Goldman Sachs Group Inc., and J.P. [read post]
25 Jan 2009, 2:36 pm
" Pfizer's acquisition of Madison, New Jersey-based Wyeth, if approved, would be the largest in almost five years in the pharmaceutical industry. [read post]
24 Jan 2009, 5:37 am
It employs 5,000 in the Phila. region.By Miriam HillInquirer Staff WriterA $60 billion purchase of drugmaker Wyeth by rival Pfizer Inc. is not a certainty, but if it does happen, it could lead to thousands of job cuts throughout Wyeth, including at its extensive Philadelphia-area operations.No one from the two pharmaceutical companies would comment yesterday on reports of ongoing acquisition talks. [read post]
23 Jan 2009, 11:58 pm
Inc. analyst Timothy Anderson predicted that Pfizer would cut 70 percent of Wyeth's current $10 billion budget for research and development, and for marketing and administrative expenses.He based his estimates on an eventual sale price of $65 billion.At the Wyeth Pharmaceuticals campus in Malvern yesterday, workers, most of whom declined to give their names, said they had heard almost nothing. [read post]
22 Jan 2009, 2:06 am
Pfizer Inc., 358 F.3d 659, 661 (9th Cir. 2004) (same; physician considered warning inappropriate) (applying California law).Under these facts, if Conte were an ordinary prescription drug product liability case, plaintiff would have been out of court and out of luck, just like Motus. [read post]
31 Dec 2008, 6:51 pm
Recent news reports have allowed us to add thirteen biotech/pharma companies and a trade group to the list: • The Pharmaceutical Research and Manufacturers of America (PhRMA), which has more than 30 members including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Novartis Corp., Pfizer Inc., and Sanofi-Aventis SA, spent more than $5.4 million on third quarter lobbying (see… [read post]
29 Dec 2008, 9:00 pm
Pfizer Inc., 867 N.Y.S.2d 425 (N.Y.A.D. 2008) (state appellate holding that plaintiff's home state controls on choice of law; similar to, but much better than, Desiano); (15) Vanderwerf v. [read post]
24 Dec 2008, 11:44 am
This Bextra lawsuit again reminded me of the injustice of preempting failure-to-warn lawsuits: Dec. 23 (Bloomberg) -- Pfizer Inc., the world's biggest drugmaker, must pay a research center $38.7 million for stealing data compiled by the foundation on its Bextra pain-killer drug, a California jury determined. [read post]
24 Dec 2008, 8:12 am
Pfizer Hit With $38 Million Jury Verdict in IP Case The Recorder A California jury awarded a $38 million verdict against Pfizer on Monday for stealing trade secrets in an effort to keep its controversial drug Bextra on the market. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
21 Nov 2008, 5:49 am
Pfizer Ltd. is the UK operating unit of Pfizer, Inc. [read post]
23 Oct 2008, 10:31 am
"        According to the AP (10/22, Tanner), other "drugs under examination are Genentech Inc.'s psoriasis drug Raptiva (efalizumab), which just last week the Food and Drug Administration (FDA) warned may contribute to a life-threatening brain illness and infections; and Exubera, an inhaled insulin product, linked with lung cancer risks," which "Pfizer Inc. stopped selling...last year. [read post]
8 Oct 2008, 11:50 am
Allergan Pharmaceuticals, Inc., 400 So.2d 820, 823 (Fla. [read post]
2 Oct 2008, 12:36 pm
Astrazeneca Pharmaceuticals, LP, 500 F.Supp.2d 736 (S.D. [read post]
18 Sep 2008, 8:56 pm
Conference of September 29, 2008 __________________ Docket: 07-811 Case name: Morris, et al. v Center for Bio-Ethical Reform, Inc. et al. [read post]